In addition, Qie et al. indicated that Fbxo4-mediated degradation of Fxr1 can effectively suppress tumorigenesis in HNSCC and that the increase in FXR1 can inhibit cellular senescence and dilute the response to tumor therapy [22]. The gene discussed is FXR1; the disease is neoplasm.